L26/P-270 Effects of insulin–transferrin–selenium (ITS) supplementation in embryo culture medium on high-grade embryo development in IVF patients with poor previous cycle outcomes
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.606 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von Y. Jeon und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Does supplementation of embryo culture medium with insulin–transferrin–selenium (ITS) improve embryo development and quality in patients with poor previous IVF outcomes? Summary answer ITS supplementation during embryo culture increased the proportion of usable blastocysts and high-grade blastocysts in poor-prognosis IVF patients. What is known already Previous research indicates that human embryos utilize less than 20% of the available metabolites in standard culture media, suggesting that conventional IVF conditions may provide suboptimal metabolic support. Several studies have demonstrated that supplementation with insulin–transferrin–selenium (ITS) enhances in vitro development of preimplantation human arrested embryos and improves cytoplasmic maturation, cleavage, and blastocyst formation in bovine oocytes. ITS provides essential nutrients, antioxidants, and growth factors that support embryonic metabolism and developmental competence. However, despite encouraging findings from animal and in vitro studies, the effects of ITS on embryo development in human IVF cycles with poor previous outcomes remain unclear. Study design, size, duration This retrospective study analyzed 160 IVF cycles from 143 women with previous IVF cycles yielding no usable embryos or only poor-quality embryos. Patients were treated consecutively at Seoul Fertility Clinic between June and December 2025. In the ITS-supplemented cycles, 1,088 oocytes were retrieved, of which 863 were mature and underwent ICSI, yielding 691 2PN zygotes. In the previous-cycle group, 1,016 oocytes were retrieved, with 819 mature oocytes undergoing ICSI and resulting in 639 2PN zygotes. Participants/materials, setting, methods Embryos were cultured immediately after ICSI in cleavage-stage medium supplemented with 0.5% ITS and incubated for 72 hours. Fertilization rates, stage-specific usable embryos, and high-grade embryo proportions were assessed. Usable embryos were defined as suitable for transfer, cryopreservation, or biopsy. High-grade embryos were identified using morphological criteria (cleavage ≥8 cells, morula ≥ fully compacted, blastocyst ≥ mid-stage BC/CB). Comparisons between groups were performed using t-tests and chi-square tests, with p < 0.05 considered statistically significant. Main results and the role of chance Fertilization rates did not differ significantly between the previous-cycle and ITS-supplemented cycles (78.0% vs. 80.1%, p = 0.302), nor did overall usable embryo rates (54.5% vs. 57.3%, p = 0.296). Stage-specific analysis revealed a significantly lower proportion of usable cleavage-stage embryos and a higher proportion of usable blastocyst-stage embryos in ITS-supplemented cycles compared with previous cycles (29.8% vs. 42.2%, p < 0.001; 31.1% vs. 15.8%, p < 0.001, respectively), while morula-stage proportions were similar between groups (39.1% vs. 42.0%, p = 0.436). In addition, the ITS-supplemented group demonstrated a significantly higher overall proportion of high-grade embryos (36.8% vs. 27.5%, p < 0.001). Stage-specific analysis showed a marked increase in high-grade blastocysts (17.7% vs. 8.0%, p < 0.001), whereas the proportions of high-grade cleavage-stage embryos (4.6% vs. 4.2%, p = 0.720) and morulae (14.5% vs. 15.3%, p = 0.658) did not differ significantly. Limitations, reasons for caution The retrospective, single-center design limits the generalizability of the findings. Clinical outcomes, including implantation and pregnancy rates, were not assessed. Prospective, multicenter studies are needed to determine whether ITS supplementation in embryo culture consistently improves embryo development and clinical outcomes. Wider implications of the findings ITS supplementation during embryo culture may enhance blastocyst formation and high-grade blastocyst proportions in patients with poor previous IVF outcomes. This offers opportunities to improve embryo development and increase the availability of usable embryos in repeated unsuccessful IVF cycles, which may be clinically relevant for patients with poor prognoses. Trial registration number No
Zitieren
APA
Jeon, Y., Park, J., Bang, S., Kim, Y., Won, J., Han, S., You, H., Hwang, J., Kim, J., Chang, E., & Lee, W. (2026). L26/P-270 Effects of insulin–transferrin–selenium (ITS) supplementation in embryo culture medium on high-grade embryo development in IVF patients with poor previous cycle outcomes. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.606
Vancouver
Jeon Y, Park J, Bang S, Kim Y, Won J, Han S, et al. L26/P-270 Effects of insulin–transferrin–selenium (ITS) supplementation in embryo culture medium on high-grade embryo development in IVF patients with poor previous cycle outcomes. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.606
BibTeX
@article{Jeon2026,
author = {Jeon, Y. and Park, J.K. and Bang, S. and Kim, Y. and Won, J. and Han, S. and You, H. and Hwang, J.Y. and Kim, J.W. and Chang, E.M. and Lee, W.S.},
title = {L26/P-270 Effects of insulin–transferrin–selenium (ITS) supplementation in embryo culture medium on high-grade embryo development in IVF patients with poor previous cycle outcomes},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.606}
}
EUVIMED